Culture of hybrid spheroids composed of calcium phosphate materials and mesenchymal stem cells on an oxygen-permeable culture device to predict in vivo bone forming capability

A variety of bone graft products have been developed to provide alternatives to autologous bone to fill bony defects. The pathway to clinical translation of bone graft materials typically involves pre-clinical studies in cell culture followed by evaluation of safety and efficacy in pre-clinical animal models. Factors including expense and a range of ethical considerations associated with pre-clinical animal models have motivated increased interest in innovative culture methods to screen bone graft materials on the pathway to clinical translation. Sato et al. report in a recent article the application of an oxygen-perfused 3D-culture model as a tool to study the osteogenic capacity of 3 calcium phosphate-based materials, as indicated by mesenchymal stem cell differentiation. The same materials were evaluated in a mouse calvarial defect model, and the authors report strong correlation between the osteogenic markers in culture and the bone formation observed in vivo. The authors suggest that 3D-culture tools such as the one investigated may enable prediction of the bone forming capacity of bone graft materials on the path to translation.

Citation Information:

Culture of hybrid spheroids composed of calcium phosphate materials and mesenchymal stem cells on an oxygen-permeable culture device to predict in vivo bone forming capability.

Sato T, Anada T, Hamai R, Shiwaku Y, Tsuchiya K, Sakai S, Baba K, Sasaki K, Suzuki O. Acta Biomater. 2019 Mar 4. pii: S1742-7061(19)30167-9. doi: 10.1016/j.actbio.2019.03.001. [Epub ahead of print]

PMID: 30844570

 

CONTACT

Osteo Science Foundation
1650 Market Street, Suite 3600
Philadelphia, PA 19103
215-977-2877
855-891-2877 Toll Free
info@osteoscience.org

Osteo Science Foundation is an independent, privately funded 501 (c) (3) non-profit organization.

SIGN UP FOR NEWS

By submitting this form, you are consenting to receive marketing emails from: Osteo Science Foundation, 1650 Market Street, Suite 2600, Philadelphia, PA, 19103, US. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact.